OLMA
Olema Pharmaceuticals, Inc.Healthcare$15.06
▲ Bullish
Mkt Cap: $1.31B|Float: 67.4M|SI: 12.2%|DTC: 4.1
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
127.7%
52W Range
$3-$36
ATR(14)
$1.02
Exp. Move
±20.6%
P/C Ratio
0.26
Earnings
May 12
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Above
Exp. Move Wide
Low Put/Call
OLMA Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $1.1M
- Max Pain
- $19.00
- Expected Move
- ±20.6%
- Put/Call OI
- 0.26
- Net Premium
- $0.0M
- Spot Price
- $15.06
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$3.10 | ±20.6% | $11.96 | $18.16 |
| 2026-05-15 | 43 | ±$5.10 | ±33.9% | $9.96 | $20.16 |
| 2026-07-17 | 106 | ±$3.95 | ±26.2% | $11.11 | $19.01 |
| 2026-10-16 | 197 | ±$4.30 | ±28.6% | $10.76 | $19.36 |
| 2026-12-18 | 260 | ±$10.88 | ±72.2% | $4.19 | $25.94 |
| 2027-01-15 | 288 | ±$9.60 | ±63.8% | $5.46 | $24.66 |
Explore OLMA options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.